Open access
Jul 2026
Design, structure-based optimization and antiviral evaluation of potent inhibitors for the macrodomain Mac1 of SARS-CoV-2
A complete structure-activity relationship of Mac1 of SARS-CoV-2, that was used to design potent nucleotide inhibitors, were reported, which were developed into membrane-permeable, non-toxic prodrugs, which strongly suppress viral replication.
Maximilian Sandmann, Sahra Tajdar, Simon Sander et al.
· Nature Communications · 0 citations